Search results
Results from the WOW.Com Content Network
Elevated LDL cholesterol is a major risk factor for atherosclerosis, a condition that can lead to heart attacks, strokes, and cardiovascular disease. [ 22 ] [ 23 ] The high content of added sugars in many ultra-processed foods can lead to obesity, inflammation, and high blood pressure, all of which are risk factors for heart and cardiovascular ...
There is no evidence that sweetened beverages are a direct cause of cancer. [36] [37] There is an indirect relationship between sugar-sweetened beverage consumption and increased risk of obesity-related cancers. [38] [39] They are related to cancer risk in their association with excess body weight.
A newer sweetener on the market, allulose has a similar texture and flavor to sugar with far fewer calories and grams of carbohydrates. This sugar substitute is naturally found in only a few foods ...
Drinking sugary soda regularly may increase the risk of cancer, as obesity is a known risk factor for various types of cancer. Additionally, the caramel coloring used in some sodas contains a ...
Sucralose is about 600 times sweeter than sucrose (table sugar), [4] [5] 3 times as sweet as both aspartame and acesulfame potassium, and 2 times as sweet as sodium saccharin. [4] The commercial success of sucralose-based products stems from its favorable comparison to other low-calorie sweeteners in terms of taste, stability, and safety.
New research suggested that Splenda (which, yes, is hidden inside that bottle of Diet Pepsi) may cause serious health problems, including cancer, Eat Clean reports.
Multiple reviews have found no link between artificial sweeteners and the risk of cancer. [46] [60] [61] [62] FDA scientists have reviewed scientific data regarding the safety of aspartame and different sweeteners in food, concluding that they are safe for the general population under common intake conditions. [63]
Past studies link the consumption of fructose or high-fructose corn syrup to an increased risk for Alzheimer’s disease, type 2 diabetes, fatty liver disease, kidney disease, and cancer.